Developing the Framework for Effective Relationships with Industry

TriMed Staff | | Health Imaging | Screening
In this session, Heart Rhythm Society (HRS) leadership will share the recently-approved guidance document on defining the society’s role in collaborating with industry. Participants will interact with several authors of the document to learn why the right collaboration with industry is critical to driving innovation. Attendees also will learn the policies that the Society has in place to ensure that relationships with industry are ethical, transparent and protect the credibility of HRS and its members

Chair: Bruce D. Lindsay, MD, Cleveland Clinic Foundation in Cleveland

Presentations:
Thursday, May 5, 12:15 PM - 1:45 PM
Panelist: Bruce L. Wilkoff, MD, Cleveland Clinic in Cleveland

Thursday, May 5, 12:15 PM - 1:45 PM
Panelist: Rachel Lampert, MD, Yale University School of Medicine in New Haven, Conn.

Thursday, May 5, 12:15 PM - 1:45 PM
Panelist: Richard L. Page, MD, University of Wisconsin School of Medicine and Public Health in Madison, Wis.

Thursday, May 5, 12:15 PM - 1:45 PM
Panelist: Anne B. Curtis, MD, University at Buffalo in Buffalo, N.Y.

TriMed Staff

Related Content

Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility

Around the web

Radiology Business
AI can help radiology standardize image exam data labeling

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.